Assisted Reproductive Technology Global Market Opportunities And Strategies To 2033
상품코드:1507987
리서치사:The Business Research Company
발행일:2024년 07월
페이지 정보:영문 393 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계 보조생식술(ART) 시장은 2018년 286억 2,400만 달러로 평가되었으며, 2023년까지 연평균 5.0% 이상 성장할 것으로 예상됩니다.
PCOS의 유병률 증가
다낭성 난소증후군(PCOS)의 높은 유병률이 실적 기간 동안 보조생식술(ART) 시장의 성장을 뒷받침한 것으로 나타났습니다. 난소를 가진 가임기 여성에게 가장 흔한 내분비(호르몬) 질환으로, 전체 인구의 5-10%가 앓고 있으며, 인공수정은 PCOS 환자에게 맞춤화된 치료 옵션을 제공하여 PCOS와 관련된 생식 관련 문제를 해결하고 임신 및 임신 성공 가능성을 높입니다. 체외수정은 난소에서 난자를 채취하여 실험실에서 정자와 수정시킨 후 배아를 자궁에 이식하는 고급 ART 치료법으로, PCOS는 여성 불임의 주요 원인 중 하나이며 "무배란성"(배란이 없는) 불임의 80%를 차지하는 것으로 추산됩니다. 체외수정은 PCOS 여성의 임신 가능성을 높이기 위한 가장 일반적인 치료법 중 하나입니다. 또한, 스위스의 전문 기관인 WHO에 따르면 전 세계적으로 약 1억 1,600만 명(3.4%)의 여성이 PCOS를 앓고 있는 것으로 추정하고 있습니다. 따라서, PCOS 사례 증가는 지난 기간 동안 보조생식술(ART) 시장의 성장을 주도했습니다.
목차
제1장 주요 요약
보조생식기술(ART) - 시장의 매력과 거시경제 상황
제2장 목차
제3장 표 리스트
제4장 그래프 리스트
제5장 보고서의 구성
제6장 시장 특징
일반적인 시장의 정의
개요
보조생식기술(ART) 시장 정의와 세분화
시장 세분화 : 기술별
체외수정(IVF)
인공수정(AI-IUI)
기타 기술
시장 세분화 : 시술 유형별
신선 비기증자
신규 기증자
동결 기증자
동결 비기증자
배아 또는 난자 은행
시장 세분화 : 최종사용자별
병원
불임 치료 클리닉
기타 최종사용자
시장 세분화 진단 : 검사별
배란 검사
자궁 난관 조영술
난소 예비 검사
유전자 검사
기타 검사
제7장 주요 시장 동향
제8장 보조생식기술(ART) 시장 : 거시경제 시나리오
COVID-19의 영향 : 보조생식기술(ART) 시장
우크라이나 전쟁의 영향 : 보조생식기술(ART) 시장
고인플레이션의 영향 : 보조생식기술(ART) 시장
제9장 세계 시장 규모와 성장
시장 규모
시장 성장 실적, 2018-2023
시장 성장 촉진요인, 2018-2023년
시장 성장 억제요인, 2018-2023년
시장 성장 예측, 2023-2028년, 2033년
시장 성장 촉진요인, 2023-2028년
시장 성장 억제요인, 2023-2028년
제10장 세계의 보조생식기술(ART) 시장 : 세분화
세계의 보조생식기술(ART) 시장 : 기술별, 분석과 예측, 2018-2023년, 2028년, 2033년
세계의 보조생식기술(ART) 시장 : 시술 유형별, 분석과 예측, 2018-2023년, 2028년, 2033년
세계의 보조생식기술(ART) 시장 : 최종사용자별, 분석과 예측, 2018-2023년, 2028년, 2033년
보조생식기술(ART) 검사 시장(ART 검사/진단), 분석과 예측, 2018-2023년, 2028년, 2033년
세계의 기타 검사 시장 : ART 검사/진단별, 분석과 예측, 2018-2023년, 2028년, 2033년
제11장 보조생식기술(ART) 시장 : 지역 및 국가별 분석
세계의 보조생식기술(ART) 시장 : 지역별, 분석과 예측, 2018-2023년, 2028년, 2033년
세계의 보조생식기술(ART) 시장 : 국가별, 분석과 예측, 2018-2023년, 2028년, 2033년
제12장 아시아태평양 시장
제13장 서유럽 시장
제14장 동유럽 시장
제15장 북미 시장
제16장 남미 시장
제17장 중동 시장
제18장 아프리카 시장
제19장 경쟁 구도와 기업 개요
Vitrolife AB
Ferring B.V.
Progyny Inc.
CooperSurgical Inc.
FUJIFILM Irvine Scientific, Inc.
제20장 경쟁 벤치마킹
제21장 경쟁 대시보드
제22장 주요 인수합병(M&A)
Hamilton Thorne Acquired Gynetics Medical Products
Reproductive Medicine Associates(RMA) And IVI-RMA Acquired Conceptions Reproductive Associates of Colorado
BPEA EQT Acquired Indira IVF
Calibre Scientific Acquired Microm UK Limited And Scopescreen
Liverpool Partners Acquired Genea Ltd.
제23장 기회와 전략
세계의 보조생식기술(ART) 시장(2028년) : 새로운 기회를 제공하는 국가
세계의 보조생식기술(ART) 시장(2028년) : 새로운 기회를 제공하는 부문
세계의 보조생식기술(ART) 시장(2028년) : 성장 전략
시장 동향에 근거한 전략
경쟁 전략
제24장 보조생식기술(ART) 시장 : 결론과 제안
결론
제안
제품
장소
가격
프로모션
사람들
제25장 부록
LSH
영문 목차
영문목차
Assisted reproductive technology (ART) refers to fertility treatments and procedures that involve the manipulation of eggs, sperm or embryos to increase the likelihood of a successful pregnancy in humans. ART includes all fertility treatments in which either the eggs or the embryos are handled.
The assisted reproductive technology (ART) market consists of sales, by entities (organizations, sole traders and partnerships), of assisted reproductive technology (ART) procedures that are used for the treatment of infertility.
The global assisted reproductive technology (ART) market was valued at $28,624.0 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 5.0%.
Increasing Prevalence Of PCOS
The high prevalence of PCOS (polycystic ovary syndrome) condition supported the assisted reproductive technology market growth in the historic period. PCOS is a hormonal disorder that occurs in women of reproductive age. It is the most common endocrine (hormone) disorder in reproductive-age people with ovaries, affecting, conservatively, 5-10% of that population. ART offers tailored treatment options for individuals with PCOS, addressing the specific reproductive challenges associated with the condition and increasing the likelihood of successful conception and pregnancy. IVF is a more advanced ART procedure that involves the retrieval of eggs from the ovaries, fertilization with sperm in a laboratory setting, and transferring resulting embryos into the uterus. PCOS is one of the leading causes of female infertility, responsible for an estimated 80% of "anovulatory" (no ovulation) infertility cases. IVF is one of the most common treatments for women to increase fertility in women with PCOS. Furthermore, according to WHO, a Switzerland-based specialized agency, approximately 116 million women (3.4%) are affected by PCOS globally. Therefore, increased cases of PCOS drove the assisted reproductive technology market growth in the historic period.
Impact Of Artificial Intelligence On Assisted Reproductive Technology
Several key players operating in the assisted reproductive technology market are integrating efforts to introduce technological innovations, such as artificial intelligence (AI) software, to advance IVF treatment outcomes and lower the costs of the treatment. In IVF, AI algorithms analyze vast amounts of data from patient medical records, lab tests and imaging studies to identify patterns and make predictions. For instance, in October 2022, Alife, a US-based AI-based health technology firm, launched new artificial intelligence software to help fertility clinics optimize and support clinical decision-making during critical stages of the IVF process. Alife uses AI and significant U.S. IVF data sets to examine millions of patient cycle data points. The company's technology can help optimize the IVF treatment process from start to finish by reducing clinic operations and giving patients a more tailored experience.
The global assisted reproductive technology market is fairly fragmented, with a large number of players operating in the market. The top ten competitors in the market made up to 17.9% of the total market in 2022.
Assisted Reproductive Technology Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global assisted reproductive technology market as it emerges from the COVID-19 shut down.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Where is the largest and fastest-growing market for assisted reproductive technology? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The assisted reproductive technology market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider assisted reproductive technology market; and compares it with other markets.
The report covers the following chapters
Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by technology, by diagnosis/testing, by procedure type and by end-user.
Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the assisted reproductive technology market.
Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by technology, by diagnosis/testing, by procedure type and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
Competitive Dashboard- Briefs on competitive dashboard of major players.
Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations- This section includes recommendations for assisted reproductive technology providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:
1) By Technology: In Vitro-Fertilization (IVF); Artificial Insemination (AI-IUI); Other Technologies
2) By Procedure Type: Fresh Non-Donor; Fresh Donor; Frozen Donor; Frozen Non-Donor; Embryo or Egg Banking
3) By End-User: Hospitals; Fertility Clinics; Other End-Users
4) By Testing/Diagnosis: In Ovulation Testing; Hysterosalpingography; Ovarian Reserve Testing; Genetic Testing; Other Tests
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; assisted reproductive technology indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
10 Global Assisted Reproductive Technology Market Segmentation
10.1 Global Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.2 Global Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.3 Global Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.4 Global Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.4.1 Global Other Tests Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
11 Assisted Reproductive Technology Market, Regional and Country Analysis
11.1 Global Assisted Reproductive Technology Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
11.2 Global Assisted Reproductive Technology Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12 Asia-Pacific Market
12.1 Summary
12.1.1 Market Overview
12.1.2 Region Information
12.1.3 Market Information
12.1.4 Background Information
12.1.5 Government Initiatives
12.1.6 Regulations
12.1.7 Regulatory Bodies
12.1.8 Major Associations
12.1.9 Taxes Levied
12.1.10 Corporate Tax Structure
12.1.11 Investments
12.1.12 Major Companies
12.2 Asia-Pacific Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.3 Asia-Pacific Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.4 Asia-Pacific Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.5 Asia-Pacific Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.6 Asia-Pacific Assisted Reproductive Technology Market: Country Analysis
12.7 China Market
12.8 Summary
12.8.1 Market Overview
12.8.2 Country Information
12.8.3 Market Information
12.8.4 Background Information
12.8.5 Government Initiatives
12.8.6 Regulations
12.8.7 Regulatory Bodies
12.8.8 Major Associations
12.8.9 Taxes Levied
12.8.10 Corporate Tax Structure
12.8.11 Investments
12.8.12 Major Companies
12.9 China Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.10 China Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.11 China Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.12 China Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.13 India Market
12.14 India Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.15 India Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.16 India Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.17 India Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.18 Japan Market
12.19 Japan Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.20 Japan Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.21 Japan Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.22 Japan Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.23 Australia Market
12.24 Australia Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.25 Australia Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.26 Australia Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.27 Australia Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.28 Indonesia Market
12.29 Indonesia Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.30 Indonesia Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.31 Indonesia Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.32 Indonesia Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.33 South Korea Market
12.34 South Korea Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.35 South Korea Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.36 South Korea Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.37 South Korea Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13 Western Europe Market
13.1 Summary
13.1.1 Market Overview
13.1.2 Region Information
13.1.3 Market Information
13.1.4 Background Information
13.1.5 Government Initiatives
13.1.6 Regulations
13.1.7 Regulatory Bodies
13.1.8 Major Associations
13.1.9 Taxes Levied
13.1.10 Corporate Tax Structure
13.1.11 Investments
13.1.12 Major Companies
13.2 Western Europe Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.3 Western Europe Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.4 Western Europe Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.5 Western Europe Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.6 Western Europe Assisted Reproductive Technology Market: Country Analysis
13.7 UK Market
13.8 UK Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.9 UK Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.10 UK Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.11 UK Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.12 Germany Market
13.13 Germany Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.14 Germany Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.15 Germany Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.16 Germany Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.17 France Market
13.18 France Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.19 France Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.20 France Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.21 France Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.22 Italy Market
13.23 Italy Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.24 Italy Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.25 Italy Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.26 Italy Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.27 Spain Market
13.28 Spain Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.29 Spain Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.30 Spain Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.31 Spain Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14 Eastern Europe Market
14.1 Summary
14.1.1 Market Overview
14.1.2 Region Information
14.1.3 Market Information
14.1.4 Background Information
14.1.5 Government Initiatives
14.1.6 Regulations
14.1.7 Regulatory Bodies
14.1.8 Major Associations
14.1.9 Taxes Levied
14.1.10 Corporate Tax Structure
14.1.11 Investments
14.1.12 Major Companies
14.2 Eastern Europe Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.3 Eastern Europe Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.4 Eastern Europe Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.5 Eastern Europe Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.6 Eastern Europe Assisted Reproductive Technology Market: Country Analysis
14.7 Russia Market
14.8 Russia Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.9 Russia Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.10 Russia Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.11 Russia Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15 North America Market
15.1 Summary
15.1.1 Market Overview
15.1.2 Region Information
15.1.3 Market Information
15.1.4 Background Information
15.1.5 Government Initiatives
15.1.6 Regulations
15.1.7 Regulatory Bodies
15.1.8 Major Associations
15.1.9 Taxes Levied
15.1.10 Corporate Tax Structure
15.1.11 Investments
15.1.12 Major Companies
15.2 North America Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.3 North America Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.4 North America Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.5 North America Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.6 North America Assisted Reproductive Technology Market: Country Analysis
15.7 USA Market
15.8 Summary
15.8.1 Market Overview
15.8.2 Country Information
15.8.3 Market Information
15.8.4 Background Information
15.8.5 Government Initiatives
15.8.6 Regulations
15.8.7 Regulatory Bodies
15.8.8 Major Associations
15.8.9 Taxes Levied
15.8.10 Corporate Tax Structure
15.8.11 Investments
15.8.12 Major Companies
15.9 USA Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.10 USA Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.11 USA Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.12 USA Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.13 Canada Market
15.14 Canada Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.15 Canada Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.16 Canada Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.17 Canada Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16 South America Market
16.1 Summary
16.1.1 Market Overview
16.1.2 Region Information
16.1.3 Market Information
16.1.4 Background Information
16.1.5 Government Initiatives
16.1.6 Regulations
16.1.7 Regulatory Bodies
16.1.8 Major Associations
16.1.9 Taxes Levied
16.1.10 Corporate Tax Structure
16.1.11 Investments
16.1.12 Major Companies
16.2 South America Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.3 South America Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.4 South America Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.5 South America Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.6 South America Assisted Reproductive Technology Market: Country Analysis
16.7 Brazil Market
16.8 Brazil Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.9 Brazil Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.10 Brazil Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.11 Brazil Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
17 Middle East Market
17.1 Summary
17.1.1 Market Overview
17.1.2 Region Information
17.1.3 Market Information
17.1.4 Background Information
17.1.5 Government Initiatives
17.1.6 Regulations
17.1.7 Regulatory Bodies
17.1.8 Major Associations
17.1.9 Taxes Levied
17.1.10 Corporate Tax Structure
17.1.11 Investments
17.1.12 Major Companies
17.2 Middle East Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
17.3 Middle East Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
17.4 Middle East Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
17.5 Middle East Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
18 Africa Market
18.1 Summary
18.1.1 Market Overview
18.1.2 Region Information
18.1.3 Market Information
18.1.4 Background Information
18.1.5 Government Initiatives
18.1.6 Regulations
18.1.7 Regulatory Bodies
18.1.8 Major Associations
18.1.9 Taxes Levied
18.1.10 Corporate Tax Structure
18.1.11 Investments
18.1.12 Major Companies
18.2 Africa Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
18.3 Africa Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
18.4 Africa Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
18.5 Africa Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
19 Competitive Landscape And Company Profiles
19.1 Vitrolife AB
19.1.1 Company Overview
19.1.2 Products And Services
19.1.3 Business Strategy
19.1.4 Financial performance
19.2 Ferring B.V.
19.2.1 Company Overview
19.2.2 Products And Services
19.2.3 Business Strategy
19.2.4 Financial performance
19.3 Progyny Inc.
19.3.1 Company Overview
19.3.2 Products And Services
19.3.3 Business Strategy
19.3.4 Financial Performance
19.4 CooperSurgical Inc.
19.4.1 Company Overview
19.4.2 Products And Services
19.4.3 Business Strategy
19.4.4 Financial Overview
19.5 FUJIFILM Irvine Scientific, Inc.
19.5.1 Company Overview
19.5.2 Products And Services
19.5.3 Business Strategy
19.5.4 Financial Overview
20 Competitive Benchmarking
21 Competitive Dashboard
22 Key Mergers And Acquisitions
22.1 Hamilton Thorne Acquired Gynetics Medical Products
22.2 Reproductive Medicine Associates (RMA) And IVI-RMA Acquired Conceptions Reproductive Associates of Colorado
22.3 BPEA EQT Acquired Indira IVF
22.4 Calibre Scientific Acquired Microm UK Limited And Scopescreen
22.5 Liverpool Partners Acquired Genea Ltd.
23 Opportunities And Strategies
23.1 Global Assisted Reproductive Technology Market In 2028 - Countries Offering Most New Opportunities
23.2 Global Assisted Reproductive Technology Market In 2028 - Segments Offering Most New Opportunities
23.3 Global Assisted Reproductive Technology Market In 2028 - Growth Strategies
23.3.1 Market Trend Based Strategies
23.3.2 Competitor Strategies
24 Assisted Reproductive Technology Market, Conclusions And Recommendations